Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03451825
Title Phase I/II Study of Avelumab in Pediatric Cancer Subjects
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Age Groups: adult | child
Covered Countries USA | CAN | BEL

No variant requirements are available.